Search

everythinglearnresearchcommunity

for

Search:↓

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Examining more lymph nodes can improve survival rates in breast cancer patients without lymph node involvement.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Polycystic Ovary Syndrome (PCOS) is a complex disorder with both immediate and long-term health effects, including menstrual issues, infertility, and increased risk of diabetes and heart disease.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Some breast cancer chemotherapy can cause permanent hair loss.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Hair can be used to measure cancer-related chemicals noninvasively.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

A group has developed therapies that show promise for treating cancer and various other conditions.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.